10-Q: Quarterly report

SEC announcementMay 14 16:08 ET · Announcements

BioCardia to Host 2023 Financial Results and Corporate Update Conference Call on March 27, 2024

Yahoo FinanceMar 20 07:00 ET

BioCardia Announces CMS Approval of Coverage for CardiAMP Cell Therapy Confirmatory Phase III Heart Failure Study

Yahoo FinanceMar 12 07:00 ET

BioCardia Reports Positive Interim Results From Phase III CardiAMP Cell Therapy Heart Failure Trial, With Compelling Data in Subgroup With Elevated NTproBNP Biomarker for Heart Failure

Yahoo FinanceMar 4 08:00 ET

BioCardia (NASDAQ:BCDAW) Trading 17.1% Higher

BioCardia, Inc. (NASDAQ:BCDAW – Get Rating)'s stock price traded up 17.1% during trading on Tuesday . The stock traded as high as $1.01 and last traded at $0.88. 1,309 shares changed hands during mid-

Defense WorldApr 5, 2023 03:01 ET

BioCardia (NASDAQ:BCDAW) Shares Down 28.9%

BioCardia, Inc. (NASDAQ:BCDAW – Get Rating) shares traded down 28.9% on Friday . The company traded as low as $0.74 and last traded at $1.01. 13,539 shares traded hands during mid-day trading, an incr

Defense WorldMar 11, 2023 03:26 ET